An underground economy for unlicensed slimming drugs is propelled by TikTok fitness influencers and vendors on messaging platforms, according to recent findings.
Experimental Treatment Gaining Traction Online
The experimental drug, which is still in research studies, is being advertised by social media influencers for its alleged fat-burning effects. Followers are urged to contact these accounts privately for source information, while also receiving promotional offers.
Active Trade on Messaging Platforms
Separately, a flourishing market exists on messaging services, where communities with thousands of members share “before and after” images, administration instructions and claims of rapid UK delivery. Sellers market the drug there before directing buyers to other platforms for transactions.
Learning About The Experimental Drug
Retatrutide is an investigational injectable created by American pharmaceutical company Eli Lilly. The treatment affects three intestinal hormones – GLP-1, GIP and glucagon. Preliminary studies indicate it could help individuals lose up to 25% of their body weight. Referred to as the “triple G”, the substance is being hailed digitally as the next Ozempic.
Healthcare Professionals Express Worries
Nevertheless, doctors and pharmacists have cautions that the distribution of what remains an unlicensed drug in the UK is worrisome and could lead to users injecting products of uncertain source.
Several professionals said the demand for the experimental drug could be connected to the increasing cost of licensed slimming products such as Mounjaro.
Regulatory Position and Implementation
Selling retatrutide on social media or Telegram is illegal in the United Kingdom, as it is an unlicensed medication that cannot be marketed or distributed for human use under the Human Medicines Regulations 2012.
Several influencers attempt to sidestep the rules by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but promotion and distribution can still breach medicines, marketing, and consumer regulations, risking fines, prosecution or imprisonment.
Service Response and Content Elimination
According to TikTok, the service has taken down problematic material and banned related keywords and search suggestions. The company stated it was dedicated to keeping the platform safe and allocating resources in strengthening compliance measures.
Digital Marketplace Activities
Investigations also found groups with up to 9,000 participants marketing retatrutide using the platform's integrated discovery tool, which operates like a online catalog. Entering “retatrutide” immediately displays groups with numerous of members, filled with images of weight loss, positive testimonials and detailed guides for preparing or injecting at home.
After minutes of entering one group, a vendor shared WhatsApp details, where most purchases occur. The seller sent an guidebook and promised shipping within two days. When asked whether the product was genuine, one seller responded: “You can’t be sure.” Another shared a photo of a alleged laboratory certificate. Not one asked about body mass, health issues or previous experience.
Item Information and Costs
Inside these groups, posts show black plastic parcels with Royal Mail stickers, stating to contain new batches. One message stated: “It took eight of us to load them this morning.”
Buyers can choose between dry substance containers, prepared at residence with sterile water, or pre-filled injectors typically priced at 160 pounds for 20mg. When questioned how long a pen should be used, vendors give contradictory answers varying between a few weeks to “depends on your body”.
Service Oversight and Safety Measures
A spokesperson for Telegram stated it regularly monitored harmful material on its platform including content that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.
Medical Professional Cautions
“Individuals are administering materials they cannot confirm. Even if the science behind retatrutide is valid, these digital products may not include what they claim,” said a pharmacy expert, the director of pharmaceutical services at a pharmacy service.
Dr Crystal Wyllie of Asda Online Doctor linked the increase in interest to current cost increases for authorized slimming medications such as Mounjaro. “With prices increasing, patients are turning to social media. But counterfeit injections are highly dangerous. You cannot know what’s inside or whether the conditions they were produced in was clean,” she said.
Her team has previously seen patients harmed by self-injection from unverified sources. “We understand the disappointment, but buying from messaging apps or WhatsApp is gambling with your health,” said the doctor. “These materials could be contaminated or incorrectly dosed.”
Producer Statement
A representative from the pharmaceutical company stated the substance was in third stage clinical trials and had not been reviewed or authorized by any government authority anywhere in the world. “Therefore at this point no one can market [it] for human use,” they explained, adding that any product “misleadingly claiming itself as a Lilly investigational substance not yet approved … may subject patients to potentially serious health risks”.
